Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis

BACKGROUND: The CHOICES study randomized participants with HIV and opioid use disorder (OUD) to HIV clinic-based extended-release naltrexone (XR-NTX), which requires complete cessation of opioid use, versus treatment-as-usual (i.e., buprenorphine, methadone). Study participants randomized to XR-NTX...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffman, Kim A., Baker, Robin, Fanucchi, Laura C., Lum, Paula J., Kunkel, Lynn E., Ponce Terashima, Javier, McCarty, Dennis, Jacobs, Petra, Korthuis, P. Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579672/
https://www.ncbi.nlm.nih.gov/pubmed/34758887
http://dx.doi.org/10.1186/s13722-021-00277-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579672/
https://www.ncbi.nlm.nih.gov/pubmed/34758887
http://dx.doi.org/10.1186/s13722-021-00277-z

Ejemplares similares